Home Applications 021437 Application 021437
Type NDA
Sponsor GD SEARLE LLC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 INSPRA EPLERENONE TABLET;ORAL 25MG Yes No 002 INSPRA EPLERENONE TABLET;ORAL 50MG Yes Yes 003 INSPRA EPLERENONE TABLET;ORAL 100MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021437-001 INSPRA EPLERENONE 25MG TABLET / ORAL AB RLD 2002-09-27 N021437-002 INSPRA EPLERENONE 50MG TABLET / ORAL AB RLD, RS 2002-09-27 N021437-003 INSPRA EPLERENONE 100MG TABLET / ORAL 2002-09-27
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 132 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 c2088c7a36db…2026-09-14 22:38:34 2026-08 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021437-002 INSPRA 50MG TABLET / ORAL AB RLD, RS 2002-09-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021437-003 INSPRA 100MG TABLET / ORAL 2002-09-27 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021437-001 INSPRA 25MG TABLET / ORAL AB RLD 2002-09-27 79d66fd596c7…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 88 observed states.
Observed Orange Book patent history# Patent history page 2 of 7 · 246 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021437-003 6534093 2019-12-08 U-3 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021437-003 6534093 2019-12-08 U-537 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021437-003 6558707 2019-12-08 U-537 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021437-003 7157101 2019-12-08 U-664 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021437-003 6410524*PED 2020-05-05 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021437-003 6747020*PED 2020-05-05 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021437-003 6410054*PED 2020-06-08 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021437-003 6495165*PED 2020-06-08 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021437-003 6534093*PED 2020-06-08 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021437-003 6558707*PED 2020-06-08 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021437-003 7157101*PED 2020-06-08 Pediatric extension 74a2ff9319b5…2020-12-22 03:56 UTC 2020-12 N021437-001 6410524*PED 2020-05-05 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-001 6747020*PED 2020-05-05 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-001 6410054*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-001 6495165*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-001 6534093*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-001 6558707*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-001 7157101*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-002 6410524*PED 2020-05-05 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-002 6747020*PED 2020-05-05 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-002 6410054*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-002 6495165*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-002 6534093*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-002 6558707*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-002 7157101*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-003 6410524*PED 2020-05-05 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-003 6747020*PED 2020-05-05 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-003 6410054*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-003 6495165*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-003 6534093*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-003 6558707*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N021437-003 7157101*PED 2020-06-08 Pediatric extension 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N021437-001 6410524*PED 2020-05-05 Pediatric extension c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021437-001 6747020*PED 2020-05-05 Pediatric extension c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021437-001 6410054*PED 2020-06-08 Pediatric extension c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021437-001 6495165*PED 2020-06-08 Pediatric extension c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021437-001 6534093*PED 2020-06-08 Pediatric extension c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021437-001 6558707*PED 2020-06-08 Pediatric extension c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021437-001 7157101*PED 2020-06-08 Pediatric extension c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N021437-002 6410524*PED 2020-05-05 Pediatric extension c0c555d07b60…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 17 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0025-1710 Inspra eplerenone G.D. Searle LLC Division of Pfizer Inc NDA Current 0025-1710 Inspra eplerenone G.D. Searle LLC Division of Pfizer Inc NDA Current 0025-1710 Inspra eplerenone G.D. Searle LLC Division of Pfizer Inc NDA Current 0025-1710 Inspra eplerenone Pfizer Laboratories Div Pfizer Inc NDA Current 0025-1710 Inspra eplerenone Pfizer Laboratories Div Pfizer Inc NDA Current 0025-1720 Inspra eplerenone G.D. Searle LLC Division of Pfizer Inc NDA Current 0025-1720 Inspra eplerenone G.D. Searle LLC Division of Pfizer Inc NDA Current 0025-1720 Inspra eplerenone G.D. Searle LLC Division of Pfizer Inc NDA Current 0025-1720 Inspra eplerenone Pfizer Laboratories Div Pfizer Inc NDA Current 0025-1720 Inspra eplerenone Pfizer Laboratories Div Pfizer Inc NDA Current 21695-797 Inspra eplerenone Rebel Distributors Corp NDA Current 59762-1710 Eplerenone eplerenone Greenstone LLC NDA AUTHORIZED GENERIC Current 59762-1710 Eplerenone eplerenone Greenstone LLC NDA AUTHORIZED GENERIC Current 59762-1710 Eplerenone eplerenone Greenstone LLC NDA AUTHORIZED GENERIC Current 59762-1720 Eplerenone eplerenone Greenstone LLC NDA AUTHORIZED GENERIC Current 59762-1720 Eplerenone eplerenone Greenstone LLC NDA AUTHORIZED GENERIC Current 59762-1720 Eplerenone eplerenone Greenstone LLC NDA AUTHORIZED GENERIC Current